MedPath

Strategies for combatting sedentariness in type 1 diabetes

Not Applicable
Completed
Conditions
Prevention of hyperglycaemia and vascular risk factors in patients with Type 1 diabetes mellitus
Nutritional, Metabolic, Endocrine
Type 1 diabetes mellitus
Registration Number
ISRCTN13641847
Lead Sponsor
niversity of Leeds
Brief Summary

2024 Results article in https://pubmed.ncbi.nlm.nih.gov/38558524/ (added 03/04/2024)

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
32
Inclusion Criteria

1. Diagnosed with type 1 diabetes for a minimum of 5 years
2. Aged between 18-60 years
3. Currently being treated on a stable insulin regimen for =6 months consisting of continuous subcutaneous insulin infusion (CSII) or multiple daily insulin (MDI) of a combination of rapid-acting and long-acting insulin
4. Able to understand written English and provide a written consent form
5. Do not currently meet the recommendations for moderate-to-vigorous physical activity (150 min/week) in adults

Exclusion Criteria

1. Newly diagnosed with T1D (<5 years)
2. Not on a stable insulin regimen consisting of CSII or MDI of a combination of rapid-acting and long-acting insulin
3. Currently pregnant or seeking to become pregnant within study timelines
4. Diagnosed with overt diabetes complications (except for mild retinopathy)
5. Presenting with hypoglycaemia unawareness
6. Established and/or diagnosed medical conditions (e.g. haematological disorder, gut mobility or digestion)
7. History of eating disorders (e.g. anorexia, bulimia)
8. History of deep vein thrombosis
9. History of stroke or heart attack (within 6 months before recruitment)
10. History of malignancy
11. History of existing medical or psychiatric conditions
12. Recent history of diabetic ketoacidosis (<6 months)
13. Severe functional limitations (e.g. back pain, and walking difficulties)
14. Dietary allergies or intolerance

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath